Clinical and molecular factors that impact the efficacy of first-line crizotinib in ROS1-rearranged non-small-cell lung cancer: a large multicenter retrospective study | BMC Medicine User montaukwhaler, in the non small cell lung cancer subreddit, 16 Sep 2021